Abstract
Over the past decade, various studies have demonstrated that class I antiarrhythmic drugs should be avoided in patients with heart failure, cardiac ischaemia or a previous myocardial infarction. In contrast, class II drugs (beta-blockers) reduce morbidity and may even lower mortality in patients suffering from moderate to severe heart failure. In these patients, careful titration of the drug dosage, frequently during hospital admission, may be necessary. If in the setting of heart failure ventricular arrhythmias are symptomatic and/or sustained, patients can be treated effectively, after appropriate treatment of the underlying disease, with the class III drug amiodarone. Unfortunately, this drug does not lower overall mortality, implying that prophylactic institution of amiodarone is not indicated. Pure class III antiarrhythmic drugs like d-sotalol, ibutilide and dofetilide show a high rate of torsade de pointes. Currently, only ibutilide has been approved for clinically monitored intravenous administration. Class IV drugs, the calcium channel blockers, are still very useful for rate control of atrial fibrillation and conversion or prevention of atrioventricular nodal re-entrant tachycardias and circus movement tachycardias usi...Continue Reading
Citations
Dec 25, 2004·European Journal of Clinical Pharmacology·V H M DeneerJ R B J Brouwers
Jun 1, 2005·Progress in Lipid Research·Arlene D Albert, Kathleen Boesze-Battaglia
Apr 13, 2000·Pharmacology & Therapeutics·K Nakagawa, T Ishizaki
Aug 26, 2000·Resuscitation·H DomanovitsA N Laggner
Mar 6, 2003·Bioorganic & Medicinal Chemistry Letters·Stéphane AngenaultPierre Renard
May 17, 2000·Journal of Cardiovascular Pharmacology·H DomanovitsA N Laggner
Jul 26, 2005·Acta Pharmacologica Sinica·De-zai Dai, Feng Yu
Jan 20, 2004·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·J L Merino
Jan 6, 2001·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·T C Trujillo, P E Nolan
Sep 12, 2006·Cardiovascular Drug Reviews·De-Zai Dai
Nov 30, 2006·Annals of the New York Academy of Sciences·Max J Lab
Aug 5, 2000·Primary Care·T E Applegate
Jul 28, 1999·The Journal of the American Dental Association·B C Muzyka
Mar 13, 2003·Journal of Cardiac Surgery·De-Zai DaiLi Chen
May 18, 2007·Journal of Medicinal Chemistry·Bertrand PlouvierMichael J A Walker